The Union commerce ministry has initiated anti-dumping probe against ursodeoxycholic acid, a chemical used in drug industry, imported from China and South Korea, following a complaint filed by Arch Pharma Labs.
Arch Pharmalabs recently signed a Technology Access & Services Agreement with Orochem Technologies Inc, on an exclusive basis. The agreement allows Arch to collaborate with Orochem for using Orochem’s proprietary Simulated Moving Bed (SMB) platform for pharmaceuticals and other applications, a statement from Orochem notified.
Arch Pharmalabs India, announced the signing of a Technology Access & Services Agreement with Orochem Technologies Inc., USA, on an exclusive basis. The agreement allows Arch to collaborate with Orochem for using Orochem’s proprietary Simulated Moving Bed (SMB) platform for pharmaceutical and other applications.
India initiates anti-dumping probe against Chinese pharma chemical
The acquisition of Arch Pharma Labs will provide operational flexibility and would help Neuland Laboratories meet its growth aspirations.
Japanese companies received the highest number of drug approvals from the Drug Controller General of India in 2016, beating their American and Swiss counterparts. Out of the 20 approvals that came in the past year, five went to four Japanese companies: Eisai, Takeda, Dainippon Sumitomo and Mitsubishi Tanabe.
China's burgeoning active pharmaceutical ingredient (API) and intermediate industry has been steadily claiming market share from Indian companies, leaving several big players--including Arch Pharmalabs, Orchid Chemicals and Ind Swift Labs--under financial stress.
For years, low-priced raw material from China helped build India's generic drug industry into a global powerhouse. Now, that advantage is turning out to be the biggest weakness - if not a full-scale threat - for the country's bulk drug manufacturers.